壺化股份(003002.SZ):擬定增募資不超5.86億元 用於民爆生產線及倉儲系統自動化、信息化改造項目等
格隆匯7月28日丨壺化股份(003002.SZ)公佈2025年度向特定對象發行A股股票預案,公司本次向特定對象發行股票數量將按照募集資金總額除以發行價格確定,且不超過公司本次發行前總股本的30%,即不超過60,000,000股(含本數)。
公司本次向特定對象發行股票募集資金總額不超過人民幣5.8595億元(含本數),扣除發行費用後的募集資金淨額擬用於民爆生產線及倉儲系統自動化、信息化改造項目,礦山工程機械設備購置項目,新建年產2,000噸起爆具自動化、智能化生產線項目,補充流動資金等。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.